Exponent, Inc. (NASDAQ:EXPO) Stock Holdings Decreased by Geneva Capital Management LLC

Geneva Capital Management LLC decreased its position in shares of Exponent, Inc. (NASDAQ:EXPO) by 1.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,569,676 shares of the business services provider’s stock after selling 21,128 shares during the quarter. Exponent makes up 2.4% of Geneva Capital Management LLC’s holdings, making the stock its 10th largest holding. Geneva Capital Management LLC’s holdings in Exponent were worth $139,858,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. State Street Corp lifted its stake in shares of Exponent by 0.7% during the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock valued at $212,151,000 after buying an additional 13,644 shares in the last quarter. Geode Capital Management LLC lifted its stake in Exponent by 4.8% in the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock worth $173,597,000 after purchasing an additional 69,099 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Exponent in the 4th quarter worth $55,131,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in Exponent by 1.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 525,378 shares of the business services provider’s stock worth $46,811,000 after purchasing an additional 7,766 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Up 0.6 %

Shares of EXPO stock opened at $83.73 on Thursday. The stock has a market cap of $4.25 billion, a P/E ratio of 39.50 and a beta of 0.71. Exponent, Inc. has a 52 week low of $77.21 and a 52 week high of $115.75. The company’s fifty day simple moving average is $89.51 and its two-hundred day simple moving average is $98.59.

Exponent (NASDAQ:EXPO) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the previous year, the company posted $0.41 EPS. On average, analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Friday, March 7th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.20 annualized dividend and a yield of 1.43%. This is a boost from Exponent’s previous quarterly dividend of $0.28. Exponent’s payout ratio is presently 56.60%.

Insider Activity

In other news, VP Richard Reiss sold 1,736 shares of the company’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now directly owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.10% of the company’s stock.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.